Filed before 2025Filed 17 May 2023
Eureka Therapeutics, Inc. filed for a new convertible round
Eureka Therapeutics, Inc., a biotech company based in Emeryville, CA, filed for a new convertible round, with no sales reported yet. The filing is dated 17 May 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 May 2023
- Round
- Convertible round
- Amount sold
- None reported
- Offering size
- $20M
- Investors so far
- Not given
- Based in
- Emeryville, CA
Investors on the board
- Cherubic Ventures
- Acorn Pacific Ventures
- Yosemite Fund
- Firefall Fund
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleEureka Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 May 2023 | New filing | — | This raise |
| 24 Jan 2020 | New filing | $45M | Another raise |
| 18 Jun 2018 | New filing | $20M | Another raise |
More with Acorn Pacific Ventures on the board
- Earthshot Labs PBC$1.7M
- FarmX Inc.$18M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.